Digestive Diseases and Sciences

, Volume 57, Issue 6, pp 1618–1623 | Cite as

Upper Gastrointestinal Involvement of Crohn’s Disease: A Prospective Study on the Role of Upper Endoscopy in the Diagnostic Work-Up

  • Maria Laura Annunziata
  • Renato Caviglia
  • Luigi Giovanni Papparella
  • Michele Cicala
Original Article



Prevalence of upper gastrointestinal (GI) tract involvement in adult Crohn’s disease (CD) has been reported to be very low (0.3–5%). In routine practice, upper endoscopy is recommended only in CD patients with upper GI symptoms. Available data concerning the prevalence of asymptomatic upper GI lesions in CD patients are controversial. The aim of this study was to prospectively evaluate the prevalence of upper GI CD involvement in CD patients, irrespective of upper GI symptoms.


A series of 119 consecutive CD patients underwent clinical assessment, including occurrence and score of upper GI symptoms, and upper endoscopy with biopsy samples for histological assessment and Helicobacter pylori (Hp) infection detection. In an attempt to further recognize the upper GI tract lesions as CD or other form of inflammation, in a subgroup of CD patients, the histological and endoscopic evaluation was repeated following 12 weeks of anti-TNF-α or other treatments in association with proton-pump inhibitors.


Upper CD involvement was found in 19/119 (16%) patients. Hp infection was detected in 10/119 (8.4%) CD patients. Hp-negative focally active chronic gastritis was found in 34/119 (28.6%) CD patients. At presentation, 12/19 patients (63%) showing upper CD involvement were asymptomatic and 7 (37%) symptomatic.


A high prevalence of upper GI tract involvement has been observed in CD patients, irrespective of upper symptoms. This finding suggests the usefulness of routine upper endoscopy in the diagnostic work-up of CD patients in order to correctly classify the distribution and extent of the disease.


Crohn’s disease Prevalence Upper gastrointestinal tract Crohn’s disease FAG Upper endoscopy 


  1. 1.
    Turner D, Griffiths AM. Esophageal, gastric, and duodenal manifestations of IBD and the role of upper endoscopy in IBD diagnosis. Curr Gastroenterol Rep. 2007;9:475–478.PubMedCrossRefGoogle Scholar
  2. 2.
    Rutgeerts P, Onette E, Vantrappen G, et al. Crohn’s disease of the stomach and duodenum: a clinical study with emphasis on the value of endoscopy and endoscopic biopsies. Endoscopy. 1980;12:288–294.PubMedCrossRefGoogle Scholar
  3. 3.
    Nugent FW, Roy MA. Duodenal Crohn’s disease: an analysis of 89 cases. Am J Gastroenterol. 1989;84:249–254.PubMedGoogle Scholar
  4. 4.
    Nugent FW, Richmond M, Park SK. Crohn’s disease of the duodenum. Gut. 1977;18:115–120.PubMedCrossRefGoogle Scholar
  5. 5.
    Tan WC, Allan RN. Diffuse jejunoileitis of Crohn’s disease. Gut. 1993;34:1374–1378.PubMedCrossRefGoogle Scholar
  6. 6.
    Sawczenko A, Sandhu BK. Presenting features of inflammatory bowel disease in Great Britain and Ireland. Arch Dis Child. 2003;88:995–1000.PubMedCrossRefGoogle Scholar
  7. 7.
    Kuriyama M, Kato J, Morimoto N, et al. Specific gastroduodenoscopic findings in Crohn’s disease: comparison with findings in patients with ulcerative colitis and gastroesophageal reflux disease. Dig Liver Dis. 2008;40:468–475.PubMedCrossRefGoogle Scholar
  8. 8.
    Parente F, Cucino C, Bollani S, et al. Focal gastric inflammatory infiltrates in inflammatory bowel diseases: prevalence, immunohistochemical characteristics and diagnostic role. Am J Gastroenterol. 2000;95:705–711.PubMedCrossRefGoogle Scholar
  9. 9.
    Korelitz BI, Waye JD, Kreuning J, et al. Crohn’s disease in endoscopic biopsies of the gastric antrum and duodenum. Am J Gastroenterol. 1981;76:103–109.PubMedGoogle Scholar
  10. 10.
    Cameron DJ. Upper and lower gastrointestinal endoscopy in children and adolescents with Crohn’s disease: a prospective study. J Gastroenterol Hepatol. 1991;6:355–358.PubMedCrossRefGoogle Scholar
  11. 11.
    Oberhuber G, Puspok A, Oesterreicher C, et al. Focally enhanced gastritis: a frequent type of gastritis in patients with Crohn’s disease. Gastroenterology. 1997;112:698–706.PubMedCrossRefGoogle Scholar
  12. 12.
    Limbergen JV, Russell RK, Drummond HE, et al. Definition of phenotypic characteristics of childhood-onset inflammatory bowel disease. Gastroenterology. 2008;135:1114–1122.PubMedCrossRefGoogle Scholar
  13. 13.
    Parente F, Molteni P, Bollani S, et al. Prevalence of Helicobacter pylori, and related upper gastrointestinal lesions in patients with inflammatory bowel disease. A cross-sectional study with matching. Scand J Gastroenterol. 1997;32:1140–1146.PubMedCrossRefGoogle Scholar
  14. 14.
    Wright CL, Riddell RH. Histology of the stomach and duodenum in Crohn’s disease. Am J Surg Pathol. 1998;22:383–390.PubMedCrossRefGoogle Scholar
  15. 15.
    Halme L, Karkkainen P, Rautelin H, et al. High frequency of Helicobacter pylori-negative gastritis in patients with Crohn’s disease. Gut. 1996;38:379–383.PubMedCrossRefGoogle Scholar
  16. 16.
    Meining A, Bayerdorffer E, Bastlein E, et al. Focal inflammatory infiltrations in gastric biopsy specimens are suggestive of Crohn’s disease. Scand J Gastroenterol. 1997;32:813–818.PubMedCrossRefGoogle Scholar
  17. 17.
    Van Assche G, Axel Dignass A, Panes J, et al. The second European evidence-based consensus on the diagnosis and management of Crohn’s disease: definitions and diagnosis. JCC. 2010;4:7–27.PubMedGoogle Scholar
  18. 18.
    Silverberg MS, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol. 2005;19:5–36.PubMedGoogle Scholar
  19. 19.
    Price AB. The Sydney system: histologic division. Eur J Gastroenterol Hepatol. 1991;6:209–222.CrossRefGoogle Scholar
  20. 20.
    Bousvaros A, Antonioli DA, Colletti RB, et al. Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn’s and Colitis Foundation of America. J Pediatr Gastroenterol Nutr. 2007;44:653–674.PubMedCrossRefGoogle Scholar
  21. 21.
    El-Omar E, Penman I, Cruikshank G, et al. Low prevalence of Helicobacter pylori in inflammatory bowel disease: association with sulphasalazine. Gut. 1994;35:1385–1388.PubMedCrossRefGoogle Scholar
  22. 22.
    Zagari RM, Fuccio L, Wallander MA, et al. Gastro-oesophageal reflux symptoms, oesophagitis and Barrett’s oesophagus in the general population: the Loiano–Monghidoro study. Gut. 2008;57:1354–1359.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  • Maria Laura Annunziata
    • 1
  • Renato Caviglia
    • 1
  • Luigi Giovanni Papparella
    • 1
  • Michele Cicala
    • 1
  1. 1.Department of Digestive DiseaseUniversity Campus Bio Medico of RomeRomeItaly

Personalised recommendations